AdvantCells is a new Swedish ATMP company developing a groundbreaking method to grow more stem cells from umbilical cord blood (UCB). These expanded cells could be stored and ready for use whenever needed, making transplants faster, more accessible, and cheaper.
Company Details
- Employees
- 1
- Founded
- 2025
- Address
- Karolinska Institutet Science Park Ab, Nanna Svartz Väg 6a, Stockholm,171 65,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://advantcells-nordic.se/
- Keywords
- Cell therapy, Transplantation, ATMP, Hematopoietic stem cells, Umbilical cord blood, Bone marrow, Haematological diseases, Biotech, Startup, Gene therapy.
- HQ
- Stockholm
Advantcells Questions
Advantcells's website is https://advantcells-nordic.se/
Advantcells's LinkedIn profile is https://se.linkedin.com/company/advantcells
Advantcells has
1 employees.
View email and phone details for 1
employees at Advantcells.
Advantcells's industry is
Biotechnology Research
Advantcells's top competitors are
Suomen Uusiutuvat / Renewables Finland,
Cvx Ventures,
Solid Io,
Atlas Venture,
Quriegen,
Dirbtinis Intelektas Pramonei / Diptech.
Advantcells's categories are Biotechnology Research
Advantcells's founding year is 2025
